Strategies to Replace in Vivo Acute Systemic Toxicity Testing: The Report and Recommendations of ECVAM Workshop 50 1,2

Anon. (1994). ECVAM News & Views. ATLA 22, 7–11.

Trevan J.W. (1927). The error of determination of toxicity. Proceedings of the Royal Society, London, Series B 101, 483–514.

OECD (1987). OECD Guidelines for the Testing of Chemicals, No. 401: Acute Oral Toxicity, 7 pp. Paris, France: Organisation for Economic Cooperation and Development.

Diener W. , Siccha L. , Mischke U. , Kayser D. , & Schlede E. (1994). The biometric evaluation of the acute toxic class method (oral). Archives of Toxicology 68, 599–610.

Schlede E. , Mischke U. , Diener W. , & Kayser D. (1995). The international validation study of the acute toxic class method (oral). Archives of Toxicology 69, 659–670.

OECD (1996). OECD Guidelines for the Testing of Chemicals, No. 423: Acute Oral Toxicity — Acute Toxic Class Method, 14 pp. (Updated in 2001.) Paris, France: Organisation for Economic Cooperation and Development.

Bruce R.D. (1985). An up-and-down procedure for acute toxicity testing. Fundamental and Applied Toxicology 6, 151–157.

Lipnick R.L. , Cotruvo J.A. , Hil N. , Bruce R.D. , Stitzel K.A. , Walker A.P. , Chu I. , Goddard M. , Segal L. , Springer J.A. , & Myers R.C. (1995). Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures. Food and Chemical Toxicology 33, 223–231.

Van den Heuvel M.J. , Clark D.G. , Fielder R. , Koundakjian P.P. , Oliver G.J.A. , Pelling D. , Tomlinson N.J. , & Walker A.P. (1990). The international validation of a fixed-dose procedure as an alternative to the classical LD50 test. Food and Chemical Toxicology 28, 469–482.

OECD (1992). OECD Guidelines for the Testing of Chemicals, No. 420: Acute Oral Toxicity — Fixed Dose Method, 7 pp. Paris, France: Organisation for Economic Cooperation and Development.

Balls M. , & Fentem J.H. (1993). The on-going process to replace the LD50 test. Humane Innovations and Alternatives 7, 544–547.

Ekwall B. (1983). Correlation between cytotoxicity in vitro and LD50 values. Acta Pharmacologica et Toxicologica 52, Suppl. 2, 80–99.

Clothier R.H. , Hulme L.M. , Smith M. , & Balls M. (1987). Comparison of the in vitro toxicities of 59 chemicals. Molecular Toxicology 1, 571–577.

Phillips J.C. , Gibson W.B. , Yam J. , Alden C.L. , & Hard G. (1990). Survey of the QSAR and in vitro approaches for developing non-animal methods to supersede the in vivo LD50 test. Food and Chemical Toxicology 28, 375–394.

Fry J.R. , Garle M.J. , Hammond A.H. , & Hatfield A. (1990). Correlation of acute lethal potency with in vitro cytotoxicity. Toxicology in Vitro 4, 175–178.

Shrivastava R. , Delomenie C. , Chevalier A. , John G. , Ekwall B. , Walum E. , & Massingham R. (1992). Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals. Cell Biology and Toxicology 8, 157–170.

Garle M.J. , Fentem J.H. , & Fry J.R. (1994). In vitro cytotoxicity tests for the prediction of acute toxicity in vivo. Toxicology in Vitro 8, 1303–1313.

Blaauboer B.J. , Barratt M.D. , & Houston J.B. (1999). The integrated use of alternative methods in toxicological risk evaluation. ATLA 27, 229–237.

ICCVAM (2001). Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity. ICCVAM–NICEATM workshop, Arlington, VA, USA, October 17–20, 2000. NIH Publication No. 01-4499, 370 pp. Research Triangle Park, NC, USA: NIEHS. Website http://iccvam.niehs.nih.gov/ (Accessed 11.10.04).

Seibert H. , Balls M. , Fentem J.H. , Bianchi V. , Clothier R.H. , Dierickx P.J. , Ekwall B. , Garle M.J. , Gómez-Lechón M.J. , Gribaldo L. , Gulden M. , Liebsch M. , Rasmussen E. , Roguet R. , Shrivastava R. , & Walum E. (1996). Acute toxicity testing in vitro and the classification and labelling of chemicals. The report and recommendations of ECVAM workshop 16. ATLA 24, 499–510.

Anon. (1967). Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European Communities P196, 1–98.

Anon. (1993). Council Regulation (EEC) No 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances. Official Journal of the European Communities L84, 1–75.

Anon. (1991). Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. Official Journal of the European Communities L230, 1–32.

Anon. (1998). Council Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market. Official Journal of the European Communities L123, 1–63.

Anon. (1992). Council Directive 92/32/EEC of 30 April 1992 amending for the seventh time Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European Communities L154, 1–29.

European Commission (2001). White Paper on a Strategy for a Future Chemicals Policy, COM(2001) 88 final, 32 pp. Website http://europa.eu.int/eur-lex/en/com/wpr/2001/com2001_0088en01.pdf (Accessed 5.10.04).

Anon. (1994). Commission Regulation (EC) No 1488/94 of 28 June 1994 laying down the principles for the assessment of risks to man and the environment of existing substances in accordance with Council Regulation (EEC) No 793/93. Official Journal of the European Communities L161, 3–11.

Anon. (2003). Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances and Directive 98/8/EC of the European Parliament and of the Council Concerning the Placing of Biocidal Products on the Market, EUR 20418 EN, 1008 pp. Website http://ecb.jrc.it (Accessed 20.10.04).

European Commission (2003). Proposal for a Regulation of the European Parliament and of the Council Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Establishing a European Chemicals Agency and Amending Directive 1999/45/EC and Regulation (EC) {on Persistent Organic Pollutants} and Proposal for a Directive of the European Parliament and of the Council Amending Council Directive 67/548/EEC in Order to Adapt it to Regulation (EC) of the European Parliament and of the Council Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals, COM(2003) 644 final, 158 pp. Website http://europa.eu.int/eur-lex/en/com/pdf/2003/com2003_0644en.html (Accessed 11.10.04).

Allanou R. , Hansen B.G. , & van der Bilt Y. (1999). Public Availability of Data on EU High Production Volume Chemicals, EUR 18996 EN, 21 pp. Website http://ecb.jrc.it (Accessed 11.10.04).

Pedersen F. , de Bruijn J. , Munn S. , & van Leeuwen K. (2003). Assessment of Additional Testing Needs under REACH. Effects of (Q)SARS, Risk Based Testing and Voluntary Industry Initiatives, EUR 20863 EN, 36 pp. Website http://ihcp.jrc.cec.eu.int/ (Accessed 11.10.04).

Anon. (2003). 40 CFR 152. 2003. Title 40: Protection of Environment Agency. Code of Federal Regulations. Part 152: Pesticide Registration and Classification Procedures 21, 6–43. Washington, DC, USA: Government Printing Office.

Anon. (2003). 40 CFR 156. 2003. Title 40: Protection of Environment Agency. Code of Federal Regulations. Part 156: Labeling Requirements for Pesticides and Devices 21, 56–73. Washington, DC, USA: Government Printing Office.

Anon. (2003). 49 CFR 173. 2003. Title 49: Department of Transportation. Code of Federal Regulations. Part 173: Shippers — General Requirements for Shipments and Packagings 2, 404–638. Washington, DC, USA: Government Printing Office.

Anon. (2003). Globally Harmonized System of Classification and Labelling of Chemicals (GHS), ST/SG/AC.10/30, 443 pp. New York, NY, USA and Geneva, Switzerland: United Nations. Website http://www.unece.org/trans/danger/publi/ghs/officialtext.html (Accessed 11.10.04).

Halle W. (2003). The Registry of Cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce animal testing. ATLA 31, 89–198.

Parchment R. (2000). Oncology clinical trials and in vitro prediction models for xenobiotic toxicology. Developments in Animal and Veterinary Sciences A 31, 693–708.

Zbinden G. , & Flury-Roversi M. (1981). Significance of the LD50-test for the toxicological evaluation of chemical substances. Archives of Toxicology 47, 77–99.

Gribaldo L. , Bueren J. , Deldar A. , Hokland P. , Meredith C. , Moneta D. , Mosesso P. , Parchment R. , Parent-Massin D. , Pessina A. , San Roman J. , & Schoeters G. (1996). The use of in vitro systems for evaluating haematotoxicity. The report and recommendations of ECVAM workshop 14. ATLA 24, 211–231.

Pessina A. , Albella B. , Bueren J. , Brantom P. , Casati S. , Gribaldo L. , Croera C. , Gagliardi G. , Foti P. , Parchment R. , Parent-Massin D. , Sibiril Y. , & Van Den Heuvel R. (2001). Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicology in Vitro 15, 729–740.

Pessina A. , Albella B. , Bayo M. , Bueren J. , Brantom P. , Casati S. , Croera C. , Gagliardi G. , Foti P. , Parchment R. , Parent-Massin D. , Schoeters G. , Sibiril Y. , Van Den Heuvel R. , & Gribaldo L. (2003). Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicological Sciences 75, 355–367.

Clemedson C. , Nordin-Andersson M. , Bjerregaard H.F. , Clausen J. , Forsby A. , Gustafsson H. , Hansson U. , Isomaa B. , Jørgensen C. , Kolman A. , Kotova N. , Krause G. , Kristen U. , Kurppa K. , Romert L. , & Scheers E. (2002). Development of an in vitro test battery for the estimation of acute human systemic toxicity: an outline of the EDIT project. ATLA 30, 313–321.

Clemedson C. , McFarlane-Abdulla E. , Andersson M. , Barile F.A. , Calleja M.C. , Chesné C. , Clothier R. , Cottin M. , Curren R. , Daniel-Szolgay E. , Dierickx P. , Ferro M. , Fiskesjö G. , Garza-Ocañas L. , Gómez-Lechón M.J. , Gülden M. , Isomaa B. , Janus J. , Judge P. , Kahru A. , Kemp R.B. , Kerszman G. , Kristen U. , Kunimoto M. , Kärenlampi S. , Lavrijsen K. , Lewan L. , Lilius H. , Ohno T. , Persoone G. , Roguet R. , Romert L. , Sawyer T.W. , Seibert H. , Shrivastava R. , Stammati A. , Tanaka N. , Torres-Alanis O. , Voss J-U. , Wakuri S. , Walum E. , Wang X. , Zucco F. , & Ekwall B. (1996). MEIC evaluation of acute systemic toxicity. Part I. Methodology of 68 in vitro toxicity assays used to test the first 30 reference chemicals. ATLA 24, Suppl. 1, 251–272.

Clemedson C. , McFarlane-Abdulla E. , Andersson M. , Barile F.A. , Calleja M.C. , Chesné C. , Clothier R. , Cottin M. , Curren R. , Dierickx P. , Ferro M. , Fiskesjö G. , Garza-Ocañas L. , Gómez-Lechón M.J. , Gülden M. , Isomaa B. , Janus J. , Judge P. , Kahru A. , Kemp R.B. , Kerszman G. , Kristen U. , Kunimoto M. , Kärenlampi S. , Lavrijsen K. , Lewan L. , Lilius H. , Malmsten A. , Ohno T. , Persoone G. , Pettersson R. , Roguet R. , Romert L. , Sandberg M. , Sawyer T.W. , Seibert H. , Shrivastava R. , Sjöström M. , Stammati A. , Tanaka N. , Torres-Alanis O. , Voss J-U. , Wakuri S. , Walum E. , Wang X. , Zucco F. , & Ekwall B. (1996). MEIC evaluation of acute systemic toxicity. Part II. In vitro results from 68 toxicity assays used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA 24, Suppl. 1, 273–311.

Clemedson C. , Barile F.A. , Ekwall B. , Gómez-Lechón M.J. , Hall T. , Imai K. , Kahru A. , Logemann P. , Monaco F. , Ohno T. , Segner H. , Sjöström M. , Valentino M. , Walum E. , Wang X. , & Ekwall B. (1998). MEIC evaluation of acute systemic toxicity. Part III. In vitro results from 16 additional methods used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA 26, Suppl. 1, 93–129.

Clemedson C. , Andersson M. , Aoki Y. , Barile F.A. , Bassi A.M. , Calleja M.C. , Castano A. , Clothier R.H. , Dierickx P. , Ekwall B. , Ferro M. , Fiskesjö G. , Garza-Ocañas L. , Gómez-Lechón M.J. , Gülden M. , Hall T. , Imai K. , Isomaa B. , Kahru A. , Kerszman G. , Kjellstrand P. , Kristen U. , Kunimoto M. , Kärenlampi S. , Lewan L. , Lilius H. , Loukianov A. , Monaco F. , Ohno T. , Persoone G. , Romert L. , Sawyer T.W. , Segner H. , Seibert H. , Shrivastava R. , Sjöström M. , Stammati A. , Tanaka N. , Thuvander A. , Torres-Alanis O. , Valentino M. , Wakuri S. , Walum E. , Wang X. , Wieslander A. , Zucco F. , & Ekwall B. (1998). MEIC evaluation of acute systemic toxicity. Part IV. In vitro results from 67 toxicity assays used to test reference chemicals 31–50 and a comparative cytotoxicity analysis. ATLA 26, Suppl. 1, 131–183.

Ekwall B. , Clemedson C. , Crafoord B. , Ekwall B. , Hallander S. , Walum E. , & Bondesson I. (1998). MEIC evaluation of acute systemic toxicity. Part V. Rodent and human toxicity data for the 50 reference chemicals. ATLA 26, Suppl. 2, 571–616.

Ekwall B. , Barile F.A. , Castano A. , Clemedson C. , Clothier R.H. , Dierickx P. , Ekwall B. , Ferro M. , Fiskesjö G. , Garza-Ocañas L. , Gómez-Lechón M.J. , Gülden M. , Hall T. , Isomaa B. , Kahru A. , Kerszman G. , Kristen U. , Kunimoto M. , Kärenlampi S. , Lewan L. , Loukianov A. , Ohno T. , Persoone G. , Romert L. , Sawyer T.W. , Shrivastava R. , Segner H. , Stammati A. , Tanaka N. , Valentino M. , Walum E. , & Zucco F. (1998). MEIC evaluation of acute systemic toxicity. Part VI. The prediction of human toxicity by rodent LD50 values and results from 61 in vitro methods. ATLA 26, Suppl. 2, 617–658.

Clemedson C. , Barile F.A. , Chesné C. , Cottin M. , Curren R. , Ekwall B. , Ferro M. , Gómez-Lechón M.J. , Imai K. , Janus J. , Kemp R.B. , Kerszman G. , Kjellstrand P. , Lavrijsen K. , Logemann P. , McFarlane-Abdulla E. , Roguet R. , Segner H. , Thuvander A. , Walum E. , & Ekwall B. (2000). MEIC evaluation of acute systemic toxicity. Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays. ATLA 28, Suppl. 1, 161–200.

Ekwall B. , Ekwall B. , & Sjöström M. (2000). MEIC evaluation of acute systemic toxicity. Part VIII. Multivariate partial least squares evaluation, including the selection of a battery of cell line tests with a good prediction of human acute lethal peak blood concentrations for 50 chemicals. ATLA 28, Suppl. 1, 201–234.

Halle W. , & Spielmann S. (1992). Two procedures for the prediction of acute toxicity (LD50) from cytotoxicity data. ATLA 20, 40–49.

ICCVAM (2001). Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Dose for Acute Toxicity. NIH Publication No. 01-4500, 102 pp. Research Triangle Park, NC, USA: NIEHS. Website http://iccvam.niehs.nih.gov/ (Accessed 11.10.04).

Borenfreund E. , & Puerner J. (1984). A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90). Journal of Tissue Culture Methods 9, 7–9.

Boison S. , & Eggum B.O. (1991). Critical evaluation of in vitro methods for estimating digestibility in simple-stomach animals. Nutrition Research Reviews 4, 141–162.

Krul C. , Luiten-Schuite A. , Baandagger R. , Verhagen H. , Mohn G. , Feron V. , & Havenaar R. (2000). Application of a dynamic in vitro gastrointestinal model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds. Food and Chemical Toxicology 38, 783–792.

Verwei M. , Arkbage K. , Havenaar R. , van den Berg H. , Witthoft C. , & Schaafsma G. (2003). Folic acid and 5-methyltetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. Journal of Nutrition 133, 2377–2383.

Artursson P. , & Karlsson J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 175, 880–885.

Versantvoort C.H.M. , Onderwater R.C.A. , Duizer E. , van de Sandt J.J.M. , Gilde A.J. , & Groten J.P. (2002). Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: composition of active and passive transport with the human colon carcinoma Caco-2 cell line. Journal of Environmental Toxicology and Pharmacology 11, 335–344.

Heringa M.B. , Pastor D. , Algra J. , Vaes W.H.J. , & Hermens J.L.M. (2002). Negligible depletion solid-phase microextraction with radio-labeled analytes to study free concentrations and protein binding: an example with [³H]estradiol. Analytical Chemistry 74, 5993–5997.

Hermens J.L.M. , & Vaes W.H.J. (2002). Characterization of analyte binding and freely dissolved concentrations in environmental and biological materials. In Comprehensive Analytical Chemistry, Vol. 37 (ed. Pawliszyn J. ), pp. 241–252. Amsterdam, The Netherlands: Elsevier Science.

Blaauboer B.J. , Bayliss M.K. , Castell J.V. , Evelo C.T.A. , Frazier J.M. , Groen K. , Gülden M. , Guillouzo A. , Hissink A.M. , Houston J.B. , Johanson G. , de Jongh J. , Kedderis G.L. , Reinhardt C.A. , van de Sandt J.J.M. , & Semino G. (1996). The use of biokinetics and in vitro methods in toxicological risk evaluation. The report and recommendations of ECVAM workshop 15. ATLA 24, 473–497.

Blaauboer B.J. (2001). Toxicodynamic modelling and the interpretation of in vitro toxicity data. Toxicology Letters 120, 111–123.

Bogaards J.J.P. , Freidig A.P. , & van Bladeren P.J. (2001). Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling. Chemico-Biological Interactions 138, 247–265.

Van Ommen B. , de Jongh J. , van de Sandt J. , Blaauboer B. , Hissink E. , Bogaards J. , & van Bladeren P. (1995). Computer-aided biokinetic modelling combined with in vitro data. Toxicology in Vitro 9, 537–542.

Sweetman S.C. ed. (2004). Martindale: The Complete Drug Reference, 34th edn, 2768 pp. London, UK: Pharmaceutical Press.